Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy

BACKGROUND: Health system expenditure on cancer drugs is rising rapidly in many OECD countries given the costly new treatments and increased rates of use due to a growing and ageing population. These factors put considerable strain on the sustainability of health systems worldwide, sparking public d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bentley, Colene, Peacock, Stuart, Abelson, Julia, Burgess, Michael M., Demers-Payette, Olivier, Longstaff, Holly, Tripp, Laura, Lavis, John N., Wilson, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367823/
https://www.ncbi.nlm.nih.gov/pubmed/30732616
http://dx.doi.org/10.1186/s12961-019-0411-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367823/
https://www.ncbi.nlm.nih.gov/pubmed/30732616
http://dx.doi.org/10.1186/s12961-019-0411-8

Ejemplares similares